Rick C. Steenwyk

1.2k total citations
29 papers, 910 citations indexed

About

Rick C. Steenwyk is a scholar working on Molecular Biology, Spectroscopy and Pharmacology. According to data from OpenAlex, Rick C. Steenwyk has authored 29 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Spectroscopy and 6 papers in Pharmacology. Recurrent topics in Rick C. Steenwyk's work include Analytical Chemistry and Chromatography (7 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Mass Spectrometry Techniques and Applications (5 papers). Rick C. Steenwyk is often cited by papers focused on Analytical Chemistry and Chromatography (7 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Mass Spectrometry Techniques and Applications (5 papers). Rick C. Steenwyk collaborates with scholars based in United States and China. Rick C. Steenwyk's co-authors include Joseph C. Fleishaker, Zhaosheng Lin, Paul G. Pearson, Elizabeth Groeber, Larry C. Wienkers, Douglas M. Fast, Edward J. Antal, Gary Siuzdak, Hin‐Koon Woo and Marianne Manchester and has published in prestigious journals such as Analytical Chemistry, Analytical Biochemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Rick C. Steenwyk

29 papers receiving 877 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rick C. Steenwyk United States 19 304 279 143 126 87 29 910
Akihiro Miki Japan 28 590 1.9× 413 1.5× 76 0.5× 168 1.3× 128 1.5× 104 1.9k
Kei Zaitsu Japan 27 448 1.5× 587 2.1× 86 0.6× 247 2.0× 94 1.1× 77 1.7k
G. McKay Canada 22 240 0.8× 370 1.3× 400 2.8× 213 1.7× 96 1.1× 86 1.3k
Tooru Kamata Japan 23 271 0.9× 258 0.9× 75 0.5× 152 1.2× 32 0.4× 53 1.2k
Yongxin Zhu United States 20 521 1.7× 441 1.6× 67 0.5× 150 1.2× 184 2.1× 54 1.2k
Kenji Kuwayama Japan 26 611 2.0× 551 2.0× 132 0.9× 244 1.9× 199 2.3× 140 2.0k
Kenji Tsujikawa Japan 27 662 2.2× 482 1.7× 150 1.0× 267 2.1× 221 2.5× 145 2.1k
Shobha Bhattachar United States 15 115 0.4× 216 0.8× 76 0.5× 278 2.2× 38 0.4× 24 895
Scott P. Webster United Kingdom 26 86 0.3× 706 2.5× 164 1.1× 223 1.8× 52 0.6× 65 1.9k
Hassan G. Fouda United States 18 379 1.2× 206 0.7× 103 0.7× 163 1.3× 119 1.4× 36 861

Countries citing papers authored by Rick C. Steenwyk

Since Specialization
Citations

This map shows the geographic impact of Rick C. Steenwyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rick C. Steenwyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rick C. Steenwyk more than expected).

Fields of papers citing papers by Rick C. Steenwyk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rick C. Steenwyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rick C. Steenwyk. The network helps show where Rick C. Steenwyk may publish in the future.

Co-authorship network of co-authors of Rick C. Steenwyk

This figure shows the co-authorship network connecting the top 25 collaborators of Rick C. Steenwyk. A scholar is included among the top collaborators of Rick C. Steenwyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rick C. Steenwyk. Rick C. Steenwyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fernández‐Metzler, Carmen, Brad Ackermann, Fabio Garofolo, et al.. (2022). Biomarker Assay Validation by Mass Spectrometry. The AAPS Journal. 24(3). 66–66. 13 indexed citations
2.
Meissen, John K., David Pirman, Min Wan, et al.. (2016). Phenotyping hepatocellular metabolism using uniformly labeled carbon-13 molecular probes and LC-HRMS stable isotope tracing. Analytical Biochemistry. 508. 129–137. 6 indexed citations
3.
Zhang, Guodong, Zhaosheng Lin, Xiaogang Han, et al.. (2013). Strategies for quantitation of endogenous adenine nucleotides in human plasma using novel ion-pair hydrophilic interaction chromatography coupled with tandem mass spectrometry. Journal of Chromatography A. 1325. 129–136. 34 indexed citations
4.
Zhang, Yizhong, Guodong Zhang, Philip A. Clarke, et al.. (2011). Simultaneous and high‐throughput quantitation of urinary tetranor PGDM and tetranor PGEM by online SPE‐LC–MS/MS as inflammatory biomarkers. Journal of Mass Spectrometry. 46(7). 705–711. 22 indexed citations
5.
6.
7.
Morgen, Michael M., Akintunde Bello, Wei Song, et al.. (2011). Polymeric Nanoparticles for Increased Oral Bioavailability and Rapid Absorption Using Celecoxib as a Model of a Low-Solubility, High-Permeability Drug. Pharmaceutical Research. 29(2). 427–440. 115 indexed citations
8.
9.
Blatnik, Matthew & Rick C. Steenwyk. (2010). Quantification of urinary PGEm, 6-keto PGF1α and 2,3-dinor-6-keto PGF1α by UFLC–MS/MS before and after exercise. Prostaglandins & Other Lipid Mediators. 93(1-2). 8–13. 12 indexed citations
10.
Steenwyk, Rick C. & Beijing Tan. (2009). In vitroevidence for the formation of reactive intermediates of resveratrol in human liver microsomes. Xenobiotica. 40(1). 62–71. 10 indexed citations
11.
Groeber, Elizabeth, et al.. (2009). Comparison of fused-core and conventional particle size columns by LC–MS/MS and UV: Application to pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis. 50(3). 491–500. 39 indexed citations
12.
13.
Wienkers, Larry C., Rick C. Steenwyk, M J Hauer, Joseph C. Fleishaker, & Paul G. Pearson. (1998). Biotransformation of Tirilazad in Human: 3. Tirilazad A-Ring Reduction by Human Liver Microsomal 5α-Reductase Type 1 and Type 2. Journal of Pharmacology and Experimental Therapeutics. 287(2). 583–590. 3 indexed citations
14.
Wienkers, Larry C., Rick C. Steenwyk, P E Sanders, & Paul G. Pearson. (1996). Biotransformation of tirilazad in human: 1. Cytochrome P450 3A-mediated hydroxylation of tirilazad mesylate in human liver microsomes.. Journal of Pharmacology and Experimental Therapeutics. 277(2). 982–990. 37 indexed citations
15.
Wienkers, Larry C., Rick C. Steenwyk, S. A. MIZSAK, & Paul G. Pearson. (1995). In vitro metabolism of tirilazad mesylate in male and female rats. Contribution of cytochrome P4502C11 and delta 4-5 alpha-reductase.. Drug Metabolism and Disposition. 23(3). 383–392. 19 indexed citations
16.
Weber, Gregory L., Rick C. Steenwyk, Sidney D. Nelson, & Paul G. Pearson. (1995). Identification of N-Acetylcysteine Conjugates of 1,2-Dibromo-3-chloropropane: Evidence for Cytochrome P450 and Glutathione Mediated Bioactivation Pathways. Chemical Research in Toxicology. 8(4). 560–573. 15 indexed citations
17.
Ryan, Timothy P., Rick C. Steenwyk, Paul G. Pearson, & Thomas Petry. (1993). Inhibition of in vitro lipid peroxidation by 21-aminosteroids evidence for differential mechanisms. Biochemical Pharmacology. 46(5). 877–884. 13 indexed citations
18.
Fleishaker, Joseph C., Gary Peters, K. S. Cathcart, & Rick C. Steenwyk. (1993). Evaluation of the Pharmacokinetics and Tolerability of Tirilazad Mesylate, a 21‐Aminosteroid Free Radical Scavenger: II. Multiple‐Dose Administration. The Journal of Clinical Pharmacology. 33(2). 182–190. 28 indexed citations
19.
Fleishaker, Joseph C., et al.. (1991). Pharmacokinetic pharmacodynamic evaluation of the combined administration of alprazolam and fluoxetine. Psychopharmacology. 104(3). 323–327. 75 indexed citations
20.
Steenwyk, Rick C., et al.. (1991). Reversed-Liquid Phase Chromatographic Determination of Cefpodoxime in Human Plasma. Journal of Liquid Chromatography. 14(20). 3641–3656. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akihiro Miki Breakdown of academic impact, for papers by Kei Zaitsu Breakdown of academic impact, for papers by G. McKay Breakdown of academic impact, for papers by Tooru Kamata Breakdown of academic impact, for papers by Yongxin Zhu Breakdown of academic impact, for papers by Kenji Kuwayama Breakdown of academic impact, for papers by Kenji Tsujikawa Breakdown of academic impact, for papers by Shobha Bhattachar Breakdown of academic impact, for papers by Scott P. Webster Breakdown of academic impact, for papers by Hassan G. Fouda
Rankless by CCL
2026